REPORT ID 8383

Global Helminthic Infestations Therapeutics Market Research Report 2017

Publish Date
8-Nov-17
Pages
107
Format
Electronic (PDF)

In this report, the global Helminthic Infestations Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Helminthic Infestations Therapeutics in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Helminthic Infestations Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Neural Analytics, Inc.
    M3 Biotechnology, Inc.
    Cerevance
    Mitochon Pharmaceuticals, Inc.
    Peptilogics
    Farmoquimica S/A
    biOasis Technologies, Inc.
    HCA Healthcare, Inc.
    Alzeca Biosciences, Inc.
    Johnson & Johnson
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Benzimidazole
    Pyrantel
    Piperazine Citrate
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Enterobius vermicularis
    Taenia saginata
    Ascaris lumbricoides
    Trichuris trichiura
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Helminthic Infestations Therapeutics Market Research Report 2017
1 Helminthic Infestations Therapeutics Market Overview
    1.1 Product Overview and Scope of Helminthic Infestations Therapeutics
    1.2 Helminthic Infestations Therapeutics Segment by Type (Product Category)
        1.2.1 Global Helminthic Infestations Therapeutics Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Helminthic Infestations Therapeutics Production Market Share by Type (Product Category) in 2016
        1.2.3 Benzimidazole
        1.2.4 Pyrantel
        1.2.5 Piperazine Citrate
        1.2.6 Others
    1.3 Global Helminthic Infestations Therapeutics Segment by Application
        1.3.1 Helminthic Infestations Therapeutics Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Enterobius vermicularis
        1.3.3 Taenia saginata
        1.3.4 Ascaris lumbricoides
        1.3.5 Trichuris trichiura
        1.3.6 Others
    1.4 Global Helminthic Infestations Therapeutics Market by Region (2012-2022)
        1.4.1 Global Helminthic Infestations Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Helminthic Infestations Therapeutics (2012-2022)
        1.5.1 Global Helminthic Infestations Therapeutics Revenue Status and Outlook (2012-2022)
        1.5.2 Global Helminthic Infestations Therapeutics Capacity, Production Status and Outlook (2012-2022)

2 Global Helminthic Infestations Therapeutics Market Competition by Manufacturers
    2.1 Global Helminthic Infestations Therapeutics Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Helminthic Infestations Therapeutics Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Helminthic Infestations Therapeutics Production and Share by Manufacturers (2012-2017)
    2.2 Global Helminthic Infestations Therapeutics Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Helminthic Infestations Therapeutics Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Helminthic Infestations Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Helminthic Infestations Therapeutics Market Competitive Situation and Trends
        2.5.1 Helminthic Infestations Therapeutics Market Concentration Rate
        2.5.2 Helminthic Infestations Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Helminthic Infestations Therapeutics Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Helminthic Infestations Therapeutics Capacity and Market Share by Region (2012-2017)
    3.2 Global Helminthic Infestations Therapeutics Production and Market Share by Region (2012-2017)
    3.3 Global Helminthic Infestations Therapeutics Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Helminthic Infestations Therapeutics Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Helminthic Infestations Therapeutics Consumption by Region (2012-2017)
    4.2 North America Helminthic Infestations Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Helminthic Infestations Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.4 China Helminthic Infestations Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Helminthic Infestations Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Helminthic Infestations Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.7 India Helminthic Infestations Therapeutics Production, Consumption, Export, Import (2012-2017)

5 Global Helminthic Infestations Therapeutics Production, Revenue (Value), Price Trend by Type
    5.1 Global Helminthic Infestations Therapeutics Production and Market Share by Type (2012-2017)
    5.2 Global Helminthic Infestations Therapeutics Revenue and Market Share by Type (2012-2017)
    5.3 Global Helminthic Infestations Therapeutics Price by Type (2012-2017)
    5.4 Global Helminthic Infestations Therapeutics Production Growth by Type (2012-2017)

6 Global Helminthic Infestations Therapeutics Market Analysis by Application
    6.1 Global Helminthic Infestations Therapeutics Consumption and Market Share by Application (2012-2017)
    6.2 Global Helminthic Infestations Therapeutics Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Helminthic Infestations Therapeutics Manufacturers Profiles/Analysis
    7.1 Neural Analytics, Inc.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 M3 Biotechnology, Inc.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Cerevance
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Cerevance Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Mitochon Pharmaceuticals, Inc.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Peptilogics
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Peptilogics Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Farmoquimica S/A
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 biOasis Technologies, Inc.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 HCA Healthcare, Inc.
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Alzeca Biosciences, Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Johnson & Johnson
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview

8 Helminthic Infestations Therapeutics Manufacturing Cost Analysis
    8.1 Helminthic Infestations Therapeutics Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Helminthic Infestations Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Helminthic Infestations Therapeutics Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Helminthic Infestations Therapeutics Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Helminthic Infestations Therapeutics Market Forecast (2017-2022)
    12.1 Global Helminthic Infestations Therapeutics Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Helminthic Infestations Therapeutics Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Helminthic Infestations Therapeutics Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Helminthic Infestations Therapeutics Price and Trend Forecast (2017-2022)
    12.2 Global Helminthic Infestations Therapeutics Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Helminthic Infestations Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Helminthic Infestations Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Helminthic Infestations Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Helminthic Infestations Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Helminthic Infestations Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Helminthic Infestations Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Helminthic Infestations Therapeutics Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Helminthic Infestations Therapeutics Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer